Interpace Biosciences CEO Jack Stover On Diagnostics Business: 'Much Of The Growth Opportunity Is Around Awareness'Benzinga • 04/01/20
Interpace Diagnostics Issues Update Regarding Announced Contract with BCBS of MassachusettsGlobeNewsWire • 03/12/20
Interpace Biosciences Announces Acceptance of first paper Demonstrating Clinical Performance of ThyGeNEXT with ThyraMIRGlobeNewsWire • 03/02/20
Interpace Biosciences Announces Another Pricing improvement for its Thyroid AssayGlobeNewsWire • 02/11/20
Interpace Biosciences Announces Addition to Board of Directors and Changes in LeadershipGlobeNewsWire • 01/30/20
Underappreciated Drivers, Bargain Valuation, And Cash Infusion Set Interpace Up For Substantial UpsideSeeking Alpha • 01/15/20
Underappreciated Drivers, Bargain Valuation & Cash Infusion Set Interpace Up For Substantial UpsideSeeking Alpha • 01/15/20
Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital PartnersGlobeNewsWire • 01/13/20
Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett’s EsophagusGlobeNewsWire • 01/06/20
Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT®GlobeNewsWire • 12/17/19
Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in ChinaGlobeNewsWire • 12/05/19
Interpace Diagnostics Group, Inc. (IDXG) CEO Jack Stover on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/14/19
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial ResultsGlobeNewsWire • 11/13/19
Interpace Diagnostics Announces Publication of New Data on Thyroid Test UtilityGlobeNewsWire • 11/04/19
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital PartnersGlobeNewsWire • 10/17/19
Interpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in ChinaGlobeNewsWire • 09/16/19
Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. WainwrightGlobeNewsWire • 09/06/19